Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: Relation to specificity of peptide-induced anti-HIV neutralizing antibodies

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 746-750

  Vu, Hai M ^a   Myers, David ^a   De Lorimier, Robert ^a   Matthews, Thomas J ^a   Anthony Moody, M ^a   Heinly, Craig ^a   Torres, Jose V ^b,c   Haynes, Barton F ^a   Spicer, Leonard ^a,d  

^a DUKE UNIVERSITY   (United States)

^b Primate Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; RHESUS MONKEY; VIRUS INDUCTION; VIRUS NEUTRALIZATION;

EID: 0032889455     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.746-750.1999     Document Type: Article

References (14)

1. Bax, A., and D. G. Davis. 1985. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:355-360.
2. Bolton, P. H., and G. Bodcnhauscn. 1982. Relayed coherence transfer spectroscopy of heteronuclear systems: detection of remote nuclei in NMR. Chem. Phys. Lett. 89:139-144.
3. Catasti, P., J. D. Fontenot, E. M. Bradbury, and G. Gupta. 1995. Local and global structural properties of the HIV-MN V3 loop. J. Biol. Chem. 270: 2224-2232.
4. Cease, K. B., H. Margalit, J. L. Cornette, S. D. Putney, W. G. Robey, C. Ouyang, H. Z. Streicher, P. J. Fischinger, R. C. Gallo, C. DeLisi, and J. A. Berzofsky. 1987. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc. Natl. Acad. Sci. USA 84:4249-4253.
5. Chandrasekhar, K., A. T. Profy, and H. J. Dyson. 1991. Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry 30:9187-9194.
6. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Garard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
7. de Lorimier, R., M. A. Moody, B. F. Haynes, and L. D. Spicer. 1994. NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus. Biochemistry 33:2055-2061.
8. Dyson, H., and P. E. Wright. 1991. Defining solution conformations of small linear peptides. Annu. Rev. Biophys. Biophys. Chem. 20:519-538.
9. Dyson, H. J., M. Rance, R. A. Houghten, R. A. Lerner, and P. E. Wright. 1988. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J. Mol. Biol. 201:161-200.
10. Dyson, H. J., M. Rance, R. A. Houghten, P. E. Wright, and R. A. Lerner. 1988. Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J. Mol. Biol. 201:201-218.
11. Dyson, H. J., R. A. Lerner, and P. E. Wright. 1988. The physical basis for induction of protein-reactive antipeptide antibodies. Annu. Rev. Biophys. Biophys. Chem. 17:305-324.
12. Ghiara, J. B., E. A. Stura, R. L. Stanfield, A. T. Profy, and I. A. Wilson. 1994. Crystal structure of the principal neutralizing site of HIV-1. Science 264:82-85.
13. Goudsmit, J., C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, Jr., and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478-4482.
14. Hart, M. K., T. J. Palker, T. J. Matthews, A. J. Langlois, N. W. Lerche, M. E. Martin, R. M. Scearce, C. McDanal, D. P. Bolognesi, and B. F. Haynes. 1990. Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. J. Immunol. 145: 2677-2685.